Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.
Current programs include:
More disciplines coming soon……
Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions
You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.
Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.
Epilepsy: Drug development over 25 years has resulted in a variety of anti-epileptic drugs available to us in clinical neurology, and these utilise several different mechanisms of action (MoA). In this interview we discuss what should be considered as a part of that decision-making process when prescribing, including; MoA, the epilepsy syndrome, patient factors, and practical considerations.
Epilepsy: In this interview we talk about the transition of moving from paediatric to adult care, which can be a challenging time for chronic health conditions and their caring network. Epilepsy is no exception, and poor adult psycho-social outcomes have been observed for those with paediatric onset epilepsy. Through intentional and thoughtful transition care programmes we can attempt to improve outcomes, listen to learn more.
Respiratory. Asthma, superficially it seems simple to manage and mild asthma would seem simple to identify, but the more you look, the more you find there are differences and variations in the clinical expression and physiology. In this interview we discuss how to tailor treatment to each individual patient.
Respiratory. In this interview we discuss a recent study, the IMPACT study, which has looked at exacerbations and all-cause mortality differences in a head to head study comparing a number of inhaler strategies. This is an important study which answers some really important clinical questions.
Psychiatry. People with schizophrenia are well known to be at risk of metabolic syndrome, and some of the medications we use increase that risk quite markedly. Recently an audit was conducted to identify patients with schizophrenia across Australia who have metabolic problems, and look at the various interventions that might be effective for them. In this interview we discuss the key findings.
Psychiatry. When treating depression what do patients want, ‘to ameliorate depressive symptoms’ or ‘to return to normal functioning’? In this interview we discuss individualised management that takes patient’s symptoms priorities and treatment expectations into account.
Epilepsy: Epilepsy is one of the most common neurological illnesses, affecting three to four per cent of people in the developing world, and while we have a wealth of treatment options, many of these are now very old. In this interview we focus on the treatment options available to us as physicians and look at what this means to the patient and what factors we ought to consider.
Epilepsy: In Australia, up to 2,000 women on anti-epileptic drugs become pregnant each year but there is concern, particularly in the neurological community, about the possible risks for these drugs and their teratogenicity. Neurologists have to balance the risks of both seizures and the risks of the medications and striking a balance is difficult – listen to learn more.
Endocrinology. In this interview we discuss cases which are less than typical, the sort of patients that we are often referred by general practitioners. We apply the evidence to; Migraine, VTE, BRCA 1 and 2, and premature ovarian insufficiency, all situations that we’re more likely to see in secondary care. 30-minute listen
Endocrinology: There’s been a spotlight on hormone therapy and breast cancer recently. Research is showing that women do not understand the long-term health consequences of menopause. So, what do we need to consider and how should we explain the multidimensional effects of menopause and of hormone therapy to our patients? 20-minute listen
Tap the share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!